The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions
Clinical trial NCT05033964 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05033964
- Sponsor
- Elixir Medical Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-15
- Primary completion
- 2022-12-02
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.